Helix Biopharma Corp.
HBP.TO
TSX
| 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 355.40K | 47.00K | 517.40K | 1.38M | 163.60K |
| Total Receivables | 27.80K | 87.40K | 23.20K | 23.50K | 25.80K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 98.50K | 161.10K | 184.50K | 139.60K | 100.50K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 481.70K | 295.50K | 725.10K | 1.54M | 289.90K |
|
|
|||||
| Total Current Assets | 481.70K | 295.50K | 725.10K | 1.54M | 289.90K |
| Net Property, Plant & Equipment | 1.40K | 2.90K | 5.10K | 13.10K | 6.50K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 13.12M | 13.29M | 0.00 | 700.00 | 700.00 |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 13.61M | 13.59M | 730.20K | 1.55M | 297.10K |
|
|
|||||
| Total Accounts Payable | 1.47M | 1.66M | 1.29M | 2.56M | 709.00K |
| Total Accrued Expenses | 417.40K | 416.90K | 446.50K | 567.30K | 566.90K |
| Short-term Debt | 251.20K | 242.10K | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 700.00 | 700.00 | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 2.14M | 2.32M | 1.74M | 1.56M | 1.28M |
|
|
|||||
| Total Current Liabilities | 2.14M | 2.32M | 1.74M | 1.56M | 1.28M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 251.20K | 242.10K | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 2.14M | 2.32M | 1.74M | 1.56M | 1.28M |
|
|
|||||
| Common Stock & APIC | 163.47M | 164.45M | 151.75M | 144.12M | 147.40M |
| Retained Earnings | -154.76M | -155.99M | -155.54M | -147.43M | -152.14M |
| Treasury Stock & Other | 2.76M | 2.80M | 2.79M | 3.30M | 3.76M |
| Total Common Equity | 11.46M | 11.26M | -1.01M | -13.10K | -978.80K |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 11.46M | 11.26M | -1.01M | -13.10K | -978.80K |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 11.46M | 11.26M | -1.01M | -13.10K | -978.80K |
|
|
|||||